Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Efstathiou

Showing results (201-210 of 273) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 3, 2024
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926Douglas M Dahl, Joseph P Rodgers, William U Shipley, et al.
Clinical Genitourinary Cancer|January 1, 2018
Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder CancerLauren C Harshman, Abhishek Tripathi, Matthew Kaag, et al.
Urologic Oncology|October 23, 2017
The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinomaGeorgios Gakis, Tina Schubert, Todd M Morgan, et al.
European Urology|March 21, 2025
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 GuidelinesAntoine G van der Heijden, Harman Max Bruins, Albert Carrion, et al.
European Urology Oncology|July 13, 2023
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily IrradiationDouglas M Dahl, Theodore G Karrison, M Dror Michaelson, et al.
Nature Reviews. Urology|September 11, 2021
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshopElaine Chang, Andrea B Apolo, Rick Bangs, et al.
World Journal of Urology|May 19, 2015
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinomaGeorgios Gakis, Todd M Morgan, Jason A Efstathiou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2015
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinomaG Gakis, T M Morgan, S Daneshmand, et al.
Urologia Internationalis|July 28, 2016
Oncological Outcomes of Patients with Concomitant Bladder and Urethral CarcinomaGeorgios Gakis, Jason A Efstathiou, Siamak Daneshmand, et al.
European Urology|November 13, 2017
Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate CancerStephen J Ramey, Shree Agrawal, Matthew C Abramowitz, et al.
Pageof 28

Showing results (201-210 of 273) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 3, 2024
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926Douglas M Dahl, Joseph P Rodgers, William U Shipley, et al.
Clinical Genitourinary Cancer|January 1, 2018
Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder CancerLauren C Harshman, Abhishek Tripathi, Matthew Kaag, et al.
Urologic Oncology|October 23, 2017
The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinomaGeorgios Gakis, Tina Schubert, Todd M Morgan, et al.
European Urology|March 21, 2025
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 GuidelinesAntoine G van der Heijden, Harman Max Bruins, Albert Carrion, et al.
European Urology Oncology|July 13, 2023
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily IrradiationDouglas M Dahl, Theodore G Karrison, M Dror Michaelson, et al.
Nature Reviews. Urology|September 11, 2021
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshopElaine Chang, Andrea B Apolo, Rick Bangs, et al.
World Journal of Urology|May 19, 2015
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinomaGeorgios Gakis, Todd M Morgan, Jason A Efstathiou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2015
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinomaG Gakis, T M Morgan, S Daneshmand, et al.
Urologia Internationalis|July 28, 2016
Oncological Outcomes of Patients with Concomitant Bladder and Urethral CarcinomaGeorgios Gakis, Jason A Efstathiou, Siamak Daneshmand, et al.
European Urology|November 13, 2017
Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate CancerStephen J Ramey, Shree Agrawal, Matthew C Abramowitz, et al.
Pageof 28